Savant Capital, LLC Infinity Pharmaceuticals, Inc. Transaction History

Savant Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$0.77 - $1.13 $19,250 - $28,249	-25,000 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$1.43 - $1.87 $35,750 - $46,750	-25,000 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$1.01 - $2.78 $10,100 - $27,799	10,000 Added 66.67%	25,000 $29,000
Q3 2018 Oct 23, 2018	SELL	$1.72 - $2.71 $12,040 - $18,970	-7,000 Reduced 31.82%	15,000 $41,000
Q1 2018 Apr 27, 2018	BUY	$1.8 - $2.74 $10,350 - $15,755	5,750 Added 35.38%	22,000 $46,000
Q4 2017 Jan 31, 2018	BUY	$1.22 - $3.73 $19,825 - $60,612	16,250	16,250 $33,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Savant Capital, LLC with notifications on news.